<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="editorial" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Transl Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Transl Med</journal-id>
<journal-id journal-id-type="publisher-id">ATM</journal-id>
<journal-title-group>
<journal-title>Annals of Translational Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">2305-5839</issn>
<issn pub-type="epub">2305-5847</issn>
<publisher>
<publisher-name>AME Publishing Company</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28462225</article-id>
<article-id pub-id-type="pmc">5395488</article-id>
<article-id pub-id-type="publisher-id">atm-05-06-145</article-id>
<article-id pub-id-type="doi">10.21037/atm.2017.01.18</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ochoa-Repáraz</surname>
<given-names>Javier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magori</surname>
<given-names>Krisztian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kasper</surname>
<given-names>Lloyd H.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><label>1</label>Department of Biology, Eastern Washington University, Cheney, WA, <country>USA</country>;</aff>
<aff id="aff2"><label>2</label>Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Hanover, NH, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><italic>Correspondence to:</italic> Javier Ochoa-Repáraz, PhD. Department of Biology, Sci258, Eastern Washington University, Cheney, WA 99004, USA. Email: <email xlink:href="jochoareparaz@ewu.edu">jochoareparaz@ewu.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><italic>Conflicts of Interest:</italic> J Ochoa-Repáraz received funding from the National Multiple Sclerosis; K Magori reports no disclosures; LH Kasper received honoraria from a speakers bureau.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<volume>5</volume>
<issue>6</issue>
<elocation-id>145</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>2017 Annals of Translational Medicine. All rights reserved.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Annals of Translational Medicine.</copyright-holder>
</permissions>
<related-article ext-link-type="doi" id="d35e115" journal-id="Nat Commun" page="12015" related-article-type="commentary-article" vol="7" xlink:href="10.1038/ncomms12015"></related-article>
<abstract>
<p>Recent findings suggest that the intestinal microbiota of patients suffering from relapsing remitting multiple sclerosis (MS) shows changes on the relative abundances of archaeal and bacterial genera. Although the richness and overall structure of the microbiota may be similar compared to the intestinal microbiota of healthy controls, elevated and reduced frequencies suggest a dysbiotic microbiota in MS. Over the past decade experimental evidence obtained in murine models of the disease highlighted the important relevance of the microbiota in the regulation of the immune system and in the severity of the disease. More recent findings on peripheral immune cells derived from human MS patients support the initial observations that changes in the microbiota may affect immunological pathways that could exacerbate disease. However, important questions remain to be answered. For instance, it is unclear whether dysbiosis precedes disease or, if in the contrary, an autoimmune disease such as MS can lead to gut dysbiosis. In this brief discussion, we speculate about this later possibility based on findings observed in murine models of disease. Further human studies are needed to answer the dilemma and determine specific immunomodulatory pathways that could have an impact on the therapeutic approaches to treat MS.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>Microbiota</kwd>
<kwd>intestine</kwd>
<kwd>dysbiosis</kwd>
<kwd>multiple sclerosis (MS)</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>